Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India
A nanobody‑based recombinant antivenom that shields mice from deadly cobra venom could reshape snakebite treatment in India.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Latest coverage observed Most recent article currently attached to this story cluster.
- Peak measured velocity The recorded velocity reached 2.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
Source diversity sample: The Tribune · The Times of India · Labroots · Medical Xpress.
How this dossier is built: methodology · AI policy · corrections.
The obvious questions
What kind of antivenom has been created?
It is an oligoclonal nanobody‑based recombinant antivenom.
Which institution developed the antivenom?
Researchers at the Indian Institute of Science (IISc) are credited with the development.
Which snake venoms does the new antivenom target?
It is designed to neutralize venom from the Indian cobra and the king cobra.
The story so far
- Velocity & Diffusion: Coverage exploded across 4 distinct news outlets with 4 published articles, achieving a live velocity of 2.
- Primary Driver: A nanobody‑based recombinant antivenom that shields mice from deadly cobra venom could reshape snakebite treatment in India.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
Snakebite remains a major health threat in the region, accounting for tens of thousands of deaths each year. The Times of India and The Tribune report that researchers at the Indian Institute of Science created the first recombinant antivenom for these species.
Labroots describes the engineered antibodies as a novel protective strategy, while Medical Xpress questions how the results could alter annual mortality figures. Follow‑up work will move toward larger‑animal studies and assess regulatory pathways before human trials.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (67% supported) Updated 1h ago.
Sources (4)
- New antivenom offers broad protection against cobra, king cobra venom in India The Tribune · 1d ago
- New hope for snakebite victims: IISc develops first recombinant antivenom The Times of India · 1d ago
- Engineered Antibodies Provide Protection Against Cobra Toxin Labroots · 1d ago
- Snakebites kill tens of thousands every year, could our new research change that? Medical Xpress · 1d ago
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
From around our network
Related trends
Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India
A nanobody‑based recombinant antivenom shields mice from deadly Indian cobra venom, hinting at a new direction for snakebite treatment.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.